Breast Cancer Trial, Recruiting (NCT07180056)

Breast Cancer Trial, Recruiting NCT07180056 Sponsor: Wenjin Yin Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07180056 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 or older
People with breast cancer that has been confirmed by a laboratory test, where the cancer has not spread to distant parts of the body and has not come back in the same area
People whose breast cancer is hormone receptor positive (HR+) and HER2 negative (HER2-) — these are specific tumour characteristics identified through testing
People with a general health status rated between 0 and 3 on a standard medical scale (this measures how much the illness affects daily activity — confirm with trial site)
People whose doctor is planning to treat them with a type of medication called CDK4/6 inhibitors as part of their standard follow-up treatment, in line with current medical guidelines

Who may not be able to join:

People who are currently pregnant or breastfeeding
People who are unable to swallow tablets, or who have a condition that affects how their body absorbs medication through the digestive system

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Wenjin Yin, M.D., Renji Hospital,School of Medicine, Shanghai Jiaotong University

Phone: 86(21)68385569

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07180056

Sponsor: Wenjin Yin

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

Trial contact: 86(21)68385569

More information: https://clinicaltrials.gov/study/NCT07180056

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 or older
People with breast cancer that has been confirmed by a laboratory test, where the cancer has not spread to distant parts of the body and has not come back in the same area
People whose breast cancer is hormone receptor positive (HR+) and HER2 negative (HER2-) — these are specific tumour characteristics identified through testing
People with a general health status rated between 0 and 3 on a standard medical scale (this measures how much the illness affects daily activity — confirm with trial site)
People whose doctor is planning to treat them with a type of medication called CDK4/6 inhibitors as part of their standard follow-up treatment, in line with current medical guidelines

Who may not be able to join:

People who are currently pregnant or breastfeeding
People who are unable to swallow tablets, or who have a condition that affects how their body absorbs medication through the digestive system

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Wenjin Yin

Registry

ClinicalTrials.gov

Start date

28 August 2025

Est. completion

1 February 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Invasive Disease-free Survival (iDFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov